RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
In 2019, the market size of RNAi Technologies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for RNAi Technologies.
This report studies the global market size of RNAi Technologies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the RNAi Technologies production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Market Segment by Product Type
Oncology
Ocular disorders
Respiratory disorders
Liver diseases
Other
Market Segment by Application
Research
Therapeutics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the RNAi Technologies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key RNAi Technologies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of RNAi Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of RNAi Technologies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for RNAi Technologies.
This report studies the global market size of RNAi Technologies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the RNAi Technologies production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Market Segment by Product Type
Oncology
Ocular disorders
Respiratory disorders
Liver diseases
Other
Market Segment by Application
Research
Therapeutics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the RNAi Technologies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key RNAi Technologies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of RNAi Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global RNAi Technologies Market Size Growth Rate by Type (2019-2025)
1.3.2 Oncology
1.3.3 Ocular disorders
1.3.4 Respiratory disorders
1.3.5 Liver diseases
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global RNAi Technologies Market Share by Application (2019-2025)
1.4.2 Research
1.4.3 Therapeutics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global RNAi Technologies Production Value 2014-2025
2.1.2 Global RNAi Technologies Production 2014-2025
2.1.3 Global RNAi Technologies Capacity 2014-2025
2.1.4 Global RNAi Technologies Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global RNAi Technologies Market Size CAGR of Key Regions
2.2.2 Global RNAi Technologies Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global RNAi Technologies Capacity by Manufacturers
3.1.2 Global RNAi Technologies Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 RNAi Technologies Revenue by Manufacturers (2014-2019)
3.2.2 RNAi Technologies Revenue Share by Manufacturers (2014-2019)
3.2.3 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
3.3 RNAi Technologies Price by Manufacturers
3.4 Key Manufacturers RNAi Technologies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into RNAi Technologies Market
3.6 Key Manufacturers RNAi Technologies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oncology Production and Production Value (2014-2019)
4.1.2 Ocular disorders Production and Production Value (2014-2019)
4.1.3 Respiratory disorders Production and Production Value (2014-2019)
4.1.4 Liver diseases Production and Production Value (2014-2019)
4.1.5 Other Production and Production Value (2014-2019)
4.2 Global RNAi Technologies Production Market Share by Type
4.3 Global RNAi Technologies Production Value Market Share by Type
4.4 RNAi Technologies Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global RNAi Technologies Consumption by Application
6 Production by Regions
6.1 Global RNAi Technologies Production (History Data) by Regions 2014-2019
6.2 Global RNAi Technologies Production Value (History Data) by Regions
6.3 United States
6.3.1 United States RNAi Technologies Production Growth Rate 2014-2019
6.3.2 United States RNAi Technologies Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States RNAi Technologies Import & Export
6.4 European Union
6.4.1 European Union RNAi Technologies Production Growth Rate 2014-2019
6.4.2 European Union RNAi Technologies Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union RNAi Technologies Import & Export
6.5 China
6.5.1 China RNAi Technologies Production Growth Rate 2014-2019
6.5.2 China RNAi Technologies Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China RNAi Technologies Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 RNAi Technologies Consumption by Regions
7.1 Global RNAi Technologies Consumption (History Data) by Regions
7.2 United States
7.2.1 United States RNAi Technologies Consumption by Type
7.2.2 United States RNAi Technologies Consumption by Application
7.3 European Union
7.3.1 European Union RNAi Technologies Consumption by Type
7.3.2 European Union RNAi Technologies Consumption by Application
7.4 China
7.4.1 China RNAi Technologies Consumption by Type
7.4.2 China RNAi Technologies Consumption by Application
7.5 Rest of World
7.5.1 Rest of World RNAi Technologies Consumption by Type
7.5.2 Rest of World RNAi Technologies Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Alnylam Pharmaceuticals
8.1.1 Alnylam Pharmaceuticals Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of RNAi Technologies
8.1.4 RNAi Technologies Product Introduction
8.1.5 Alnylam Pharmaceuticals Recent Development
8.2 Benitec Biopharma Ltd
8.2.1 Benitec Biopharma Ltd Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of RNAi Technologies
8.2.4 RNAi Technologies Product Introduction
8.2.5 Benitec Biopharma Ltd Recent Development
8.3 Filmtec Corporation
8.3.1 Filmtec Corporation Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of RNAi Technologies
8.3.4 RNAi Technologies Product Introduction
8.3.5 Filmtec Corporation Recent Development
8.4 Ionis Pharmaceuticals
8.4.1 Ionis Pharmaceuticals Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of RNAi Technologies
8.4.4 RNAi Technologies Product Introduction
8.4.5 Ionis Pharmaceuticals Recent Development
8.5 Quark Pharmaceuticals Inc.
8.5.1 Quark Pharmaceuticals Inc. Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of RNAi Technologies
8.5.4 RNAi Technologies Product Introduction
8.5.5 Quark Pharmaceuticals Inc. Recent Development
8.6 RXI Pharmaceuticals
8.6.1 RXI Pharmaceuticals Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of RNAi Technologies
8.6.4 RNAi Technologies Product Introduction
8.6.5 RXI Pharmaceuticals Recent Development
8.7 Qiagen
8.7.1 Qiagen Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of RNAi Technologies
8.7.4 RNAi Technologies Product Introduction
8.7.5 Qiagen Recent Development
8.8 Invitrogen
8.8.1 Invitrogen Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of RNAi Technologies
8.8.4 RNAi Technologies Product Introduction
8.8.5 Invitrogen Recent Development
8.9 Ambion
8.9.1 Ambion Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of RNAi Technologies
8.9.4 RNAi Technologies Product Introduction
8.9.5 Ambion Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global RNAi Technologies Capacity, Production Forecast 2019-2025
9.1.2 Global RNAi Technologies Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global RNAi Technologies Production and Value Forecast by Regions 2019-2025
9.2.2 Global RNAi Technologies Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global RNAi Technologies Production Forecast by Type
9.7.2 Global RNAi Technologies Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 RNAi Technologies Sales Channels
10.2.2 RNAi Technologies Distributors
10.3 RNAi Technologies Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global RNAi Technologies Market Size Growth Rate by Type (2019-2025)
1.3.2 Oncology
1.3.3 Ocular disorders
1.3.4 Respiratory disorders
1.3.5 Liver diseases
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global RNAi Technologies Market Share by Application (2019-2025)
1.4.2 Research
1.4.3 Therapeutics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global RNAi Technologies Production Value 2014-2025
2.1.2 Global RNAi Technologies Production 2014-2025
2.1.3 Global RNAi Technologies Capacity 2014-2025
2.1.4 Global RNAi Technologies Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global RNAi Technologies Market Size CAGR of Key Regions
2.2.2 Global RNAi Technologies Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global RNAi Technologies Capacity by Manufacturers
3.1.2 Global RNAi Technologies Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 RNAi Technologies Revenue by Manufacturers (2014-2019)
3.2.2 RNAi Technologies Revenue Share by Manufacturers (2014-2019)
3.2.3 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
3.3 RNAi Technologies Price by Manufacturers
3.4 Key Manufacturers RNAi Technologies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into RNAi Technologies Market
3.6 Key Manufacturers RNAi Technologies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oncology Production and Production Value (2014-2019)
4.1.2 Ocular disorders Production and Production Value (2014-2019)
4.1.3 Respiratory disorders Production and Production Value (2014-2019)
4.1.4 Liver diseases Production and Production Value (2014-2019)
4.1.5 Other Production and Production Value (2014-2019)
4.2 Global RNAi Technologies Production Market Share by Type
4.3 Global RNAi Technologies Production Value Market Share by Type
4.4 RNAi Technologies Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global RNAi Technologies Consumption by Application
6 Production by Regions
6.1 Global RNAi Technologies Production (History Data) by Regions 2014-2019
6.2 Global RNAi Technologies Production Value (History Data) by Regions
6.3 United States
6.3.1 United States RNAi Technologies Production Growth Rate 2014-2019
6.3.2 United States RNAi Technologies Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States RNAi Technologies Import & Export
6.4 European Union
6.4.1 European Union RNAi Technologies Production Growth Rate 2014-2019
6.4.2 European Union RNAi Technologies Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union RNAi Technologies Import & Export
6.5 China
6.5.1 China RNAi Technologies Production Growth Rate 2014-2019
6.5.2 China RNAi Technologies Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China RNAi Technologies Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 RNAi Technologies Consumption by Regions
7.1 Global RNAi Technologies Consumption (History Data) by Regions
7.2 United States
7.2.1 United States RNAi Technologies Consumption by Type
7.2.2 United States RNAi Technologies Consumption by Application
7.3 European Union
7.3.1 European Union RNAi Technologies Consumption by Type
7.3.2 European Union RNAi Technologies Consumption by Application
7.4 China
7.4.1 China RNAi Technologies Consumption by Type
7.4.2 China RNAi Technologies Consumption by Application
7.5 Rest of World
7.5.1 Rest of World RNAi Technologies Consumption by Type
7.5.2 Rest of World RNAi Technologies Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Alnylam Pharmaceuticals
8.1.1 Alnylam Pharmaceuticals Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of RNAi Technologies
8.1.4 RNAi Technologies Product Introduction
8.1.5 Alnylam Pharmaceuticals Recent Development
8.2 Benitec Biopharma Ltd
8.2.1 Benitec Biopharma Ltd Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of RNAi Technologies
8.2.4 RNAi Technologies Product Introduction
8.2.5 Benitec Biopharma Ltd Recent Development
8.3 Filmtec Corporation
8.3.1 Filmtec Corporation Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of RNAi Technologies
8.3.4 RNAi Technologies Product Introduction
8.3.5 Filmtec Corporation Recent Development
8.4 Ionis Pharmaceuticals
8.4.1 Ionis Pharmaceuticals Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of RNAi Technologies
8.4.4 RNAi Technologies Product Introduction
8.4.5 Ionis Pharmaceuticals Recent Development
8.5 Quark Pharmaceuticals Inc.
8.5.1 Quark Pharmaceuticals Inc. Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of RNAi Technologies
8.5.4 RNAi Technologies Product Introduction
8.5.5 Quark Pharmaceuticals Inc. Recent Development
8.6 RXI Pharmaceuticals
8.6.1 RXI Pharmaceuticals Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of RNAi Technologies
8.6.4 RNAi Technologies Product Introduction
8.6.5 RXI Pharmaceuticals Recent Development
8.7 Qiagen
8.7.1 Qiagen Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of RNAi Technologies
8.7.4 RNAi Technologies Product Introduction
8.7.5 Qiagen Recent Development
8.8 Invitrogen
8.8.1 Invitrogen Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of RNAi Technologies
8.8.4 RNAi Technologies Product Introduction
8.8.5 Invitrogen Recent Development
8.9 Ambion
8.9.1 Ambion Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of RNAi Technologies
8.9.4 RNAi Technologies Product Introduction
8.9.5 Ambion Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global RNAi Technologies Capacity, Production Forecast 2019-2025
9.1.2 Global RNAi Technologies Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global RNAi Technologies Production and Value Forecast by Regions 2019-2025
9.2.2 Global RNAi Technologies Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global RNAi Technologies Production Forecast by Type
9.7.2 Global RNAi Technologies Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 RNAi Technologies Sales Channels
10.2.2 RNAi Technologies Distributors
10.3 RNAi Technologies Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
